These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 36505429)

  • 1. Modulating macrophage function to reinforce host innate resistance against
    Park HE; Lee W; Choi S; Jung M; Shin MK; Shin SJ
    Front Immunol; 2022; 13():931876. PubMed ID: 36505429
    [No Abstract]   [Full Text] [Related]  

  • 2. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K; Sano C
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced phagocytic activity of human alveolar macrophages infected with Mycobacterium avium complex.
    Ikegami H; Yamasaki K; Ogawa M; Nemoto K; Akata K; Noguchi S; Fukuda K; Kawanami T; Mukae H; Yatera K
    J Infect Chemother; 2022 Nov; 28(11):1506-1512. PubMed ID: 35926765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The New Frontier of Host-Directed Therapies for
    Crilly NP; Ayeh SK; Karakousis PC
    Front Immunol; 2020; 11():623119. PubMed ID: 33552087
    [No Abstract]   [Full Text] [Related]  

  • 5. [Non-tuberculous mycobacteriosis. What has been coming out].
    Kajiki A
    Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell deficiency and hyperinflammatory monocyte responses associate with
    Lindestam Arlehamn CS; Benson B; Kuan R; Dill-McFarland KA; Peterson GJ; Paul S; Nguyen FK; Gilman RH; Saito M; Taplitz R; Arentz M; Goss CH; Aitken ML; Horne DJ; Shah JA; Sette A; Hawn TR
    Front Immunol; 2022; 13():1016038. PubMed ID: 36263044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathophysiology of pulmonary nontuberculous mycobacterial (NTM) disease.
    Matsuyama M; Matsumura S; Nonaka M; Nakajima M; Sakai C; Arai N; Ueda K; Hizawa N
    Respir Investig; 2023 Mar; 61(2):135-148. PubMed ID: 36640546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
    Ramirez J; Mason C; Ali J; Lopez FA
    J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
    Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
    Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Involvement of
    Shin MK; Shin SJ
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809463
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotic Maintenance and Redevelopment of Nontuberculous Mycobacteria Pulmonary Disease after Treatment of Mycobacterium avium Complex Pulmonary Disease.
    Zo S; Kim H; Kwon OJ; Jhun BW
    Microbiol Spectr; 2022 Aug; 10(4):e0108822. PubMed ID: 35950873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.
    Morimoto K; Hasegawa N; Izumi K; Namkoong H; Uchimura K; Yoshiyama T; Hoshino Y; Kurashima A; Sokunaga J; Shibuya S; Shimojima M; Ato M; Mitarai S
    Ann Am Thorac Soc; 2017 Jan; 14(1):49-56. PubMed ID: 27788025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections.
    Prasla Z; Sutliff RL; Sadikot RT
    Am J Respir Cell Mol Biol; 2020 Aug; 63(2):144-151. PubMed ID: 32160017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium avium complex and other nontuberculous mycobacteria in patients with HIV infection.
    MacDonell KB; Glassroth J
    Semin Respir Infect; 1989 Jun; 4(2):123-32. PubMed ID: 2664936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host-directed therapy to combat mycobacterial infections.
    Kilinç G; Saris A; Ottenhoff THM; Haks MC
    Immunol Rev; 2021 May; 301(1):62-83. PubMed ID: 33565103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012.
    Shah NM; Davidson JA; Anderson LF; Lalor MK; Kim J; Thomas HL; Lipman M; Abubakar I
    BMC Infect Dis; 2016 May; 16():195. PubMed ID: 27154015
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Litvinov V; Makarova M; Kudlay D; Nikolenko N; Mikhailova J
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34668850
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
    Sato K; Tomioka H; Akaki T; Kawahara S
    Int J Antimicrob Agents; 2000 Sep; 16(1):25-9. PubMed ID: 11185410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.